Press releases
4 Nov 2024
SpeediCath® Flex and Luja ® catheters in Germany - information to customers
14 May 2024
Coloplast expands its Luja™ portfolio with next generation catheter for women
7 May 2024
Coloplast strengthens ostomy care portfolio with three significant product launches
31 Jan 2024
Coloplast launches Biatain® Silicone Fit for pressure injury prevention and wound management in the US
21 Jun 2023
Largest shareholder and Foundation to secure Coloplast future with new holding company
31 Mar 2023
Study shows significant improvement in bladder emptying with Coloplast's Luja™ compared to competitor catheter
3 Feb 2023
Coloplast launches male catheter designed to reduce the risk of urinary tract infections
15 Nov 2022
Coloplast appoints new President of its global Interventional Urology business
5 May 2022
Coloplast delivers a solid Q2 with 7% organic growth and a 31% EBIT margin and revises full year organic growth guidance to 6-7% from ~7% while maintaining reported growth guidance of ~15% and reported EBIT margin guidance of ~31% before special items
25 Jan 2022
Coloplast delivers solid start to the year with 6% organic growth in Q1 and a 32% EBIT margin before special items
1 Nov 2021
Coloplast delivers solid full year results in line with the company’s financial guidance after a strong Q4 performance
26 Oct 2021
Reimbursement breakthrough in Poland raises the standard of care for people living with neurogenic bladder dysfunction
6 May 2021
Coloplast delivers 2% organic growth in Q2 as well as an EBIT margin of 33% and raises full-year underlying EBIT margin guidance from 31-32% to 32-33%
2 Feb 2021
Coloplast delivers a good start to the year with 5% organic growth in Q1 and maintains its financial guidance for 2020/21
3 Nov 2020
Coloplast delivers solid full year results despite the COVID-19 pandemic and expects 7-8% organic growth and 31-32% EBIT margin for 2020/21
18 Aug 2020
Coloplast reports -2% organic growth in Q3 due to significant negative impact from COVID-19 – and 5% year to date organic growth
18 Mar 2020
Coloplast revises full-year organic growth and EBIT margin guidance for 2019/20
7 Jan 2020
Coloplast awarded Enterostomal Therapy products agreement with Premier Inc.
5 Nov 2019
Coloplast delivers a strong full-year result and the company concludes that the Interventional Urology business remains core to its future value creation
19 Aug 2019
Coloplast delivers 8% organic growth and solid performance across all business areas
9 Jul 2019
Coloplast completes its SenSura® Mio ostomy care range with new innovative products for premature babies and kids
2 May 2019
Coloplast continues solid performance in Q2 and raises expectations for reported growth in DKK
17 Apr 2019
Coloplast responds to FDA’s decision to remove Surgical Transvaginal Mesh as Treatment Option for Pelvic Organ Prolapse
12 Nov 2018
Paul Marcun returns to Coloplast as a member of the Executive Management team and new Executive Vice President of Chronic Care
1 Nov 2018
Coloplast delivers solid full-year result and 8% growth for the sixth quarter running
3 May 2018
Coloplast delivers 8% organic revenue growth and upgrades full-year growth expectations
4 Apr 2018
Coloplast expands its product portfolio with new innovative ostomy category
1 Feb 2018
Coloplast delivers solid Q1 interim results and continues to take market share
3 Nov 2017
Coloplast delivers satisfactory full-year results and increases long-term growth ambitions
1 Feb 2017
Coloplast delivers satisfactory Q1 interim results in line with expectations
26 Sep 2016
Coloplast introduces new silicone wound dressings as part of growth ambition
17 Aug 2015
Patient survey rates Coloplast best in corporate reputation for the fourth straight year
5 May 2015
Coloplast delivers H1 interim report in line with expectations after a good second quarter performance
3 Mar 2015
Coloplast receives environmental award for comprehensive climate and energy work
29 Jan 2015
Coloplast delivers stable growth in first quarter, but lowers its full-year sales growth guidance
Latest company announcements and news
View all company announcementsContact
Jakob Danving Nielsen
Have you got a question for us?
